Long-Term Reduction of Liver Fibrosis Surrogates in Syndromic Biliary Atresia

In brief

This study examines long-term liver fibrosis outcomes in patients with Biliary Atresia Splenic Malformation syndrome (BASM) following Kasai portoenterostomy. Despite similar initial surgical responses, BASM patients demonstrate reduced liver fibrosis markers over extended follow-up compared to isolated biliary atresia cases.

• BASM patients show reduced liver fibrosis progression compared to isolated BA despite similar initial Kasai response
• Long-term fibrosis surrogates differ between syndromic and non-syndromic biliary atresia phenotypes
• Congenital anomalies in BA may predict better hepatic fibrosis outcomes post-Kasai portoenterostomy

Written by the GCMD Library team from the article.